Bumper Offer - Urjas oil Just @ Rs. 1
Rosukem A 75 Capsule, a prescription drug, is manufactured in various forms such as Capsule. Other than this, Rosukem A 75 Capsule has some other therapeutic uses, which have been discussed ahead.
The right dosage of Rosukem A 75 Capsule depends on the age, gender, and medical history of the patient. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Refer to the dosage section for a detailed discussion.
Some other side effects of Rosukem A 75 Capsule have been listed ahead. Usually, these side effects of Rosukem A 75 Capsule go away soon, and do not persist beyond the duration of the treatment. If, however, they worsen or do not go away, please speak with your physician.
Rosukem A 75 Capsule's effect during pregnancy is Severe and Severe while nursing. Warnings related to Rosukem A 75 Capsule's effects on the liver, heart and kidney, if any, have been listed below.
Rosukem A 75 Capsule is contraindicated in people with pre-existing medical conditions like Kidney Disease, Hypothyroidism, Drug Allergy as it can result in adverse effects. Some other conditions that can be affected by Rosukem A 75 Capsule are listed in the contraindications section below.
Drug reaction of Rosukem A 75 Capsule with other medicines has been reported. See below for a complete list.
You should also be aware that Rosukem A 75 Capsule is safe while driving, and is addiction.
Rosukem A 75 Capsule is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Rosukem A 75 Capsule is used -
Severe
Moderate
Mild
Is the use of Rosukem A 75 Capsule safe for pregnant women?
Pregnant women may get severe side effects after taking Rosukem A. If you are pregnant, do not take Rosukem A without a doctor's advice.
Is the use of Rosukem A 75 Capsule safe during breastfeeding?
Rosukem A should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.
What is the effect of Rosukem A 75 Capsule on the Kidneys?
Rosukem A may cause harmful effects on kidney. if you feel its having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Rosukem A 75 Capsule on the Liver?
Using Rosukem A does not have any harmful effects on the liver.
What is the effect of Rosukem A 75 Capsule on the Heart?
The heart can be affected by Rosukem A. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart the medicine only after medical advice.
Rosukem A 75 Capsule should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Rosukem A 75 Capsule unless your doctor advises you to do so -
Is this Rosukem A 75 Capsule habit forming or addictive?
Rosukem A 75 Capsule does not cause addiction.
Interaction between Food and Rosukem A 75 Capsule
Information is not available on the interaction of any foods with Rosukem A 75 Capsule, due to a lack of research on this.
Interaction between Alcohol and Rosukem A 75 Capsule
Due to lack of research, there is no information about the side effects of taking Rosukem A 75 Capsule with alcohol.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Crestor (rosuvastatin calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 636,637
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Durlaza (aspirin)
KD Tripathi. Essentials of Medical Pharmacology. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 195-199
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 191-194
